美国食品和药物管理局在安全问题导致其2020年撤回后批准了重新配制的抗酸药. FDA approves reformulated antacid after safety concerns led to its 2020 withdrawal.

FDA批准了一款重新配方的流行制酸剂，距原产品因安全问题下架已有五年。 The FDA has approved a reformulated version of a popular antacid, five years after the original product was withdrawn from shelves due to safety concerns. 更新后的公式处理以前的问题,包括污染风险,现在消费者可以使用该公式,寻求场外减轻心烧和消化不良。 The updated formula addresses previous issues, including contamination risks, and is now available for consumers seeking over-the-counter relief from heartburn and indigestion. 这项批准标志着在恢复获得广泛使用的药物方面迈出了重要一步,同时确保更新安全标准。 The approval marks a significant step in restoring access to a widely used medication while ensuring updated safety standards.